← Leaderboards
Manish Kohli
Mayo Clinic Rochester
$4,072,306
Attributed
$8,439,299
Total exposure
5
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2009–25$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,439,299 · 5
By mechanism
R01$8,047,444 · 4
R21$391,855 · 1
Top collaborators
- Andrew Michael Smith6 shared
- Liang Wang6 shared
- Brian T. Cunningham4 shared
- Utkan Demirci4 shared
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Liang Wang$6,312,215
- Josep Maria Domingo-Domenech$5,429,135
- Sundeep Khosla$91,221,003
- Aaron Scott Mansfield$1,664,916
- Zhenkun Lou$18,569,951
Others in their field
Top investigators on “Chemotherapy”
- George R Seage · Abt Associates, Inc.$223,371,661
- Charles A Coltman · Southwest Oncology Group$170,244,220
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Peter C Adamson · National Childhood Cancer Foundation$154,566,243
- Philip J Disaia · University Of California Irvine$115,055,799
- Norman Wolmark · Nsabp Foundation, Inc.$106,367,723
Research focus
ChemotherapyTechnologyDocetaxelBloodMicrornasProspectiveBiological MarkersDigitalNucleic AcidsMolecularTumorValidationQuantitative Reverse Transcriptase PcrPlasmaResponseClinical TrialsMutationCastration Resistant Prostate CancerCancer PatientAdvanced Prostate CancerSuccessBaseMalignant Neoplasm Of ProstateLaboratories
Grant awards (18)
Digital Multiplexed Analysis of Circulating Nucleic Acids in Small-Volume Blood Specimens$600,953
R01 · FY2025 · EB
Digital Multiplexed Analysis of Circulating Nucleic Acids in Small-Volume Blood Specimens$572,094
R01 · FY2024 · EB
Digital Multiplexed Analysis of Circulating Nucleic Acids in Small-Volume Blood Specimens$518,921
R01 · FY2023 · EB
Exosome separation and digital resolution detection of blood-based nucleic acid biomarkers for noninvasive therapeutic diagnostics in cancer$494,678
R01 · FY2023 · EB
Cell free nucleic acid-based biomarkers in advanced prostate cancer$568,617
R01 · FY2022 · CA
Digital Multiplexed Analysis of Circulating Nucleic Acids in Small-Volume Blood Specimens$547,060
R01 · FY2022 · EB
Exosome separation and digital resolution detection of blood-based nucleic acid biomarkers for noninvasive therapeutic diagnostics in cancer$502,989
R01 · FY2022 · EB
Daily Quantification of Cancer-Associated Exosomal miRNA in Patient Blood by Photonic Crystal-Enhanced Quantum Dot Emission$308,303
R01 · FY2022 · CA
Cell free nucleic acid-based biomarkers in advanced prostate cancer$594,224
R01 · FY2021 · CA
Exosome separation and digital resolution detection of blood-based nucleic acid biomarkers for noninvasive therapeutic diagnostics in cancer$505,588
R01 · FY2021 · EB
Daily Quantification of Cancer-Associated Exosomal miRNA in Patient Blood by Photonic Crystal-Enhanced Quantum Dot Emission$369,941
R01 · FY2021 · CA
Exosome separation and digital resolution detection of blood-based nucleic acid biomarkers for noninvasive therapeutic diagnostics in cancer$556,370
R01 · FY2020 · EB
Cell free nucleic acid-based biomarkers in advanced prostate cancer$501,046
R01 · FY2019 · CA
Cell free nucleic acid-based biomarkers in advanced prostate cancer$104,750
R01 · FY2019 · CA
Cell free nucleic acid-based biomarkers in advanced prostate cancer$638,405
R01 · FY2018 · CA
Cell free nucleic acid-based biomarkers in advanced prostate cancer$663,505
R01 · FY2017 · CA
A Proteomics Approach for Identifying Predictive Factors to Androgen Deprivation$171,384
R21 · FY2010 · CA · contact PI
A Proteomics Approach for Identifying Predictive Factors to Androgen Deprivation$220,471
R21 · FY2009 · CA · contact PI